# Amendments to the Current Good Manufacturing Practice Regulations for Finished Pharmaceuticals
> **Food and Drug Administration** · Final rule. · Published 2008-09-08 · Effective 2008-12-08 · 73 FR 51919
## Document
- **Document number:** E8-20709
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 73 FR 51919
- **CFR reference:** 21 CFR 210
- **Publication date:** 2008-09-08
- **Effective date:** 2008-12-08
- **HHS docket:** Docket No. FDA-2007-N-0379
## Abstract

The Food and Drug Administration (FDA) is amending certain of its regulations on current good manufacturing practice (CGMP) requirements for finished pharmaceuticals as the culmination of the first phase of an incremental approach to modifying the CGMP regulations for these products. This rule revises CGMP requirements primarily concerning aseptic processing, verification of performance of operations by a second individual, and the use of asbestos filters. We are amending the regulations to modernize or clarify some of the requirements as well as to harmonize them with other FDA regulations and international CGMP standards.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2008/09/08/E8-20709/amendments-to-the-current-good-manufacturing-practice-regulations-for-finished-pharmaceuticals)
---
*AI Analytics · CC0 1.0*